VRAX
Virax Biolabs Group Ltd
$0.2090
-1.88%
$1.6M
No data for this timeframe.
Vol
Market Cap$1.6M
Cap SizeNano Cap
Reddit Sentiment64° Warm
SEC Reports2
Exchange Nasdaq·Sector In Vitro & In Vivo Diagnostic Substances·Inc. E9·CIK 0001885827·Prev Close $0.2130
Recent Activity
May 26, 2026
SEC
Virax Biolabs reported early pilot data for its ViraxImmune blood-based test for Long COVID and related post-acute infec
6-K — Impact 6/10
May 18, 2026
short_volume
Short Volume: VRAX — 58.3% short (172.5M / 295.8M)
Short: 172,524,522 | Exempt: 638,786 | TRF Vol: 295,773,374 | Short Ratio: 58.3% | Off-exchange volu
Apr 10, 2026
SEC
Virax Biolabs confirmed the full exercise of pre-funded warrants, adding 12.5 million ordinary shares to its outstanding
6-K — Impact 6/10
Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$1.00 (Jan 2026)
Current $0.1882
Low $1.00
Median $1.00
High $1.00
1 analysts
$1.00
$1.00
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jan 9, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $-0.40 ▲ +60.4% | $-0.40 — $-0.40 | 75% YoY | 1 |
| Next FY | $-0.24 | $-0.24 — $-0.24 | 40% YoY | 1 |
Latest Reports
BULLISH
6-K
6/10
Virax Biolabs reported early pilot data for its ViraxImmune blood-based test for Long COVID and related post-acute infec
May 26, 2026
BEARISH
6-K
6/10
Virax Biolabs confirmed the full exercise of pre-funded warrants, adding 12.5 million ordinary shares to its outstanding
Apr 10, 2026
Reddit Sentiment
64°
Warm
Bearish
Neutral
Bullish
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 6.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Jan 2026): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$1.00 mean target (Jan 2026)
$1.00 Low
$1.00 High
| Metric | Value |
|---|---|
| Current Price | $0.1882 |
| Target Low | $1.00 |
| Target Mean | $1.00 |
| Target Median | $1.00 |
| Target High | $1.00 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-03-31 |
$-0.40 | $-0.40 | $-0.40 | 75.3% | +60.4% | 1↑ 0↓ | $0.0B | -36.8% | 1 |
| Next FY 2027-03-31 |
$-0.24 | $-0.24 | $-0.24 | 40.0% | — | — | $0.0B | 0.0% | 1 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jan 9, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
64°
Warm
Bearish
Neutral
Bullish
14 mentions
5 bullish
0 bearish
11 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 25, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| May 24, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| May 19, 2026 | 2 | 58° Warm | 1 | 0 | 2 |
| May 19, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 18, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| May 18, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| May 8, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 8, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 8, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 8, 2026 | 2 | 56° Neutral | 0 | 0 | 2 |
| May 8, 2026 | 2 | 56° Neutral | 0 | 0 | 2 |
Recent Reddit Threads
Stock Pulse Weekly Recap — May 18–22, 2026
▲ 1
💬 1
⚡ 0.5
A few small caps I’m watching into the session
▲ 1
💬 1
⚡ 0.5
19 MAY 2026 , WHAT ARE THE BIGGEST WINNERS AND WHY ?
▲ 1
💬 1
⚡ 0.5
VRAX está ganando fuerza
▲ 1
💬 1
⚡ 0.5
$VRAX getting strength
▲ 1
💬 1
⚡ 0.5
VRAX Short Squeeze?
▲ 1
💬 0
⚡ 0.5
VRAX short squeeze?
▲ 1
💬 0
⚡ 0.5
May 18, 2026
short_volume
Short Volume: VRAX — 58.3% short (172.5M / 295.8M)
Short: 172,524,522 | Exempt: 638,786 | TRF Vol: 295,773,374 | Short Ratio: 58.3% | Off-exchange volume (dark pool + OTC)
May 14, 2026
short_volume
Short Volume: VRAX — 60.9% short (0.4M / 0.7M)
Short: 399,722 | Exempt: 184,616 | TRF Vol: 656,643 | Short Ratio: 60.9% | Off-exchange volume (dark pool + OTC)
May 8, 2026
short_volume
Short Volume: VRAX — 57.3% short (2.9M / 5.1M)
Short: 2,899,569 | Exempt: 24,510 | TRF Vol: 5,063,459 | Short Ratio: 57.3% | Off-exchange volume (dark pool + OTC)
Apr 23, 2026
short_volume
Short Volume: VRAX — 58.2% short (3.8M / 6.6M)
Short: 3,832,123 | Exempt: 84,215 | TRF Vol: 6,584,574 | Short Ratio: 58.2% | Off-exchange volume (dark pool + OTC)
Apr 14, 2026
short_interest
FTD: VRAX — 3,273,140 shares ($0.6M) failed to deliver
Settlement: 20260414, Price: $0.17, FTD Value: $556,433.8, VIRAX BIOLABS GROUP LTD SHS NE
Apr 13, 2026
short_volume
Short Volume: VRAX — 55.3% short (41.5M / 75.0M)
Short: 41,490,079 | Exempt: 6,856,593 | TRF Vol: 75,013,275 | Short Ratio: 55.3% | Off-exchange volume (dark pool + OTC)